News
-
-
PRESS RELEASE
EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Drägerwerk AG & Co. KGaA reports Q1 2026 preliminary results: strong earnings growth, net sales increase, and positive EBIT margin. Forecast for 2026 includes higher sales and EBIT margin -
PRESS RELEASE
AB Science fait le point sur son programme de développement clinique
AB Science obtient une assurance d'essais cliniques de 25 millions d'euros pour son étude de phase III sur la sclérose latérale amyotrophique et met en place une suspension temporaire de ses essais cliniques en Europe -
-
PRESS RELEASE
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Drägerwerk AG & Co. KGaA reports significant earnings growth in Q1 2026, with net sales up by 6.9%. Positive trends in both medical and safety divisions drive increase in EBIT and order intake -
-
-
PRESS RELEASE
Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract
Pet Service Holding and Gilbert Dupont terminate liquidity contract. Assets in the account include 7,936 shares and €12,698.01 cash balance. Pet Service Holding is a key player in pet care sector in the Netherlands -
-